Completed Research Project
Investigator(s):
Sarah M. Cheal, Ph.D.
Related Institute:
Last Updated:
June 7, 2022
We developed theranostic intraperitoneal DOTA-ligand bound radionuclide-based pretargeted radioimmunotherapy (DOTA-PRIT) for treatment of peritoneal carcinomatosis. Mol. Cancer Ther.: 2022 Jan;21(1):125-137.